A randomized, controlled pilot study to evaluate the safety and efficacy of intravitreal fluocinolone acetonide (0.5mg and 2mg) implants in patients with clinically significant diabetic macular edema.

Trial Profile

A randomized, controlled pilot study to evaluate the safety and efficacy of intravitreal fluocinolone acetonide (0.5mg and 2mg) implants in patients with clinically significant diabetic macular edema.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2013

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 11 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top